Clinical Trial Update: Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a lidocaine plus cetylpyridinium chloride lozenge for sore throat due to the common cold, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharyngitis

Drugs mentioned

• Lidocaine and cetylpyridinium chloride lozenge (lidocaine; cetylpyridinium chloride)

Snippet

Sponsor: Novartis | Conditions: Sore Throat Due to a Common Cold | Phase 3 | Status: COMPLETED | Results posted: 2012-07-26